论文部分内容阅读
用新的实验室方法生产的7种人抗体混合物被认为是一种能防止致死性细菌感染的有效保护物。这种细菌即绿脓杆菌,是住院病人经常感染而最易致命的细菌。西雅图遗传系统公司的MarkE Lostrom等集中精力研究绿脓杆菌,目的是用人们的几种抗体制造具有预防作用的混合物。绿脓杆菌至少有17种变异株,每种都具有特殊的表面分子。遗传系统公司的科学家选用其中与90％的医院感染有关的7种菌株。侵入人体的细菌的许多表面成分可
Seven human antibody mixtures produced by the new laboratory method are considered to be an effective protection against lethal bacterial infections. This bacterium, Pseudomonas aeruginosa, is the most frequently fatal bacterium in hospitalized patients. MarkE Lostrom, of Seattle Genetics, Inc., focused on Pseudomonas aeruginosa with the goal of making a mixture of prophylactic agents with several of the antibodies in humans. Pseudomonas aeruginosa has at least 17 variants, each with a special surface molecule. Genetic Systems scientists selected seven strains of which 90% were associated with nosocomial infections. Many surface components of bacteria invade the human body can be